Is a patient with severe hyperglycemia (blood glucose 557), metabolic acidosis (bicarbonate 22, anion gap 18), ketosis (ketones 0.9), impaired renal function (creatinine 1.82, GFR 37), and elevated osmolality (311) in diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

This patient is in DKA (Diabetic Ketoacidosis)

Based on the laboratory values provided, this patient meets diagnostic criteria for DKA rather than pure HHS, though there are overlapping features suggesting a mixed presentation.

Diagnostic Analysis

Why This is DKA:

The patient fulfills the three key diagnostic criteria for DKA 1, 2:

  • Hyperglycemia: Blood glucose 557 mg/dL (>250 mg/dL required for DKA) 1
  • Ketosis: Serum ketones 0.9 mmol/L (positive ketones present) 1
  • Metabolic acidosis with elevated anion gap: Anion gap 18 mEq/L (>10 mEq/L diagnostic for DKA) and bicarbonate 22 mEq/L 1, 2

Severity Classification:

This represents mild DKA based on the bicarbonate level of 22 mEq/L, which is above the typical DKA range but still consistent with mild disease 1, 2. The American Diabetes Association criteria specify:

  • Mild DKA: bicarbonate 15-18 mEq/L, anion gap >10 mEq/L 1
  • Moderate DKA: bicarbonate 10-15 mEq/L, anion gap >12 mEq/L 1
  • Severe DKA: bicarbonate <10 mEq/L, anion gap >12 mEq/L 1

Why This is NOT Pure HHS:

HHS diagnostic criteria require 1:

  • Blood glucose typically >600 mg/dL (this patient has 557 mg/dL - borderline)
  • Effective serum osmolality >320 mOsm/kg (this patient has 311 mOsm/kg - does not meet criteria)
  • Small or absent ketones (this patient has ketones 0.9 mmol/L - positive ketones present)
  • Bicarbonate >15 mEq/L (this patient has 22 mEq/L - meets this criterion)

Mixed Presentation Considerations:

This patient likely has overlapping features of both DKA and HHS, which occurs in approximately one-third of hyperglycemic crisis cases 3. The elevated osmolality (311 mOsm/kg, though below the 320 threshold for HHS) combined with positive ketones and elevated anion gap suggests a mixed picture 3.

Key Clinical Implications:

  • Renal impairment (creatinine 1.82, GFR 37) is present and common in both conditions, resulting from osmotic diuresis and dehydration 4
  • The impaired renal function may be contributing to the metabolic acidosis and limiting ketone clearance 4
  • Treatment should address both the ketoacidosis (with insulin) and the significant dehydration/hyperosmolality (with aggressive fluid resuscitation) 3

Treatment Approach:

For this mixed presentation, management should include 1, 3:

  • Intravenous insulin infusion to suppress ketogenesis and correct hyperglycemia 1
  • Aggressive fluid replacement with isotonic saline (0.9% NaCl) at 15-20 mL/kg/h initially, given the elevated osmolality and renal impairment 1
  • Electrolyte monitoring and replacement, particularly potassium, as insulin therapy will drive potassium intracellularly 1, 5
  • Frequent monitoring of glucose, electrolytes, anion gap, and venous pH every 2-4 hours 2
  • No bicarbonate therapy needed as the pH is likely >7.0 (bicarbonate only indicated if pH <6.9) 2, 6

Important Pitfall:

Standard ketone measurements using nitroprusside method only detect acetoacetate and acetone, NOT β-hydroxybutyrate (the predominant ketone body in DKA) 6. The reported ketone level of 0.9 mmol/L may underestimate the true degree of ketosis 6. During treatment, as β-hydroxybutyrate converts to acetoacetate, standard ketone measurements may paradoxically increase despite clinical improvement 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anion Gap in Diabetic Ketoacidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ketone Body Measurement and Bicarbonate Levels in Ketoacidotic States

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Why is diabetic ketoacidosis (DKA) relatively low in pancreatic diabetes?
What causes Diabetic Ketoacidosis (DKA)?
What is the most appropriate recommendation for managing type 1 diabetes mellitus in a 17-year-old patient taking insulin glargine (glargine) and insulin lispro (lispro) who wants to participate in long-distance running, with well-controlled blood glucose levels and a hemoglobin A1c (HbA1c) of 6.5%?
What should the Lantus (insulin glargine) dose, carb coverage, and correction scale be for a 49-year-old male with type 2 diabetes, previously on Metformin (metformin hydrochloride), with a history of Diabetic Ketoacidosis (DKA) and current Hyperglycemia (A1C 12.3%)?
What is the management approach for a patient with ketonuria (presence of ketones in urine) and +2 ketones?
What are the major drugs contraindicated during pregnancy and their potential side effects on the fetus?
What is the recommended dosing for an adult patient with hypertension or hyperlipidemia and potential Impaired renal function or liver disease?
What are the management and prevention strategies for a patient with a positive Methicillin-resistant Staphylococcus aureus (MRSA) nasal swab prior to surgery?
What is the recommended post-antibiotic therapy for a patient with arm cellulitis who required debridement and failed outpatient antibiotic (op abx) therapy, to be discharged home after hospital admission?
Does Celebrex (Celecoxib) increase blood pressure (BP) less than other NSAIDs, especially in patients with a history of hypertension?
What is the best treatment approach for an elderly male patient with potential chronic conditions and age-related decline, presenting with symptoms such as confusion, memory loss, or difficulty with daily activities, and possible pre-existing conditions like cardiovascular disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.